Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Bolt Biotherapeutics, Inc. (BOLT) had Pre-Tax Income of $-15.18M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
$1.14M |
|
$-15.18M |
|
-- |
|
$1.14M |
|
$17.58M |
|
$-16.44M |
|
$1.27M |
|
|
Pre-Tax Income |
$-15.18M |
$-15.18M |
|
$-15.18M |
|
$-15.18M |
|
$-15.18M |
|
$-15.18M |
|
$-16.44M |
|
$-16.49M |
|
38.25M |
|
38.25M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$57.15M |
|
$3.56M |
|
$52.19M |
|
$109.33M |
|
$18.08M |
|
$15.35M |
|
$19.22M |
|
$37.30M |
|
$72.03M |
|
$72.03M |
|
$72.03M |
|
38.27M |
|
| Cash Flow Statement Financials | |
$-46.86M |
|
$45.34M |
|
$0.08M |
|
$12.57M |
|
$11.14M |
|
$-1.44M |
|
$6.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.16 |
|
-- |
|
-- |
|
0.18 |
|
0.21 |
|
100.00% |
|
-1441.10% |
|
-1441.10% |
|
-- |
|
-1330.06% |
|
-1330.06% |
|
$-46.75M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-21.07% |
|
-21.07% |
|
-13.88% |
|
-17.37% |
|
$1.88 |
|
$-1.22 |
|
$-1.23 |
|